also important for the pharmaceutical industry of the two countries with the biotechnology company belkate signed a memorandum a year ago on long-term cooperation. the main thing is the uninterrupted supply of medicines to belarusians. both russia and part of the projects have already started so for 21 and last year belarus was supplied from these lines. there are already 11 billion drugs worth 1.7 billion russian rubles in the plans for this year drugs. they are purchased under government contracts. these are the most popular, so to speak, drugs. this is one part of the melanoma program also being developed and is probably the main challenge. this will be a program to achieve, including indicators of drug safety of the republic of belarus within the framework of some large national program. and the health of the people and demographic security. this project is not for one year sro. now the effect is being discussed. it will be possible to see in about 2-3 years experience and knowledge are also shared practice doctors. and this cooperation is invaluable. we are interested in localizing p